16 June 2020: Bioinformatics is an integrative field that develops software and systems tools for understanding the biological data. It mainly combines biology, computer science, mathematics, statistics, and information engineering to understand and examine biological data. The recognition of candidate genes and single nucleotide polymorphisms (SNPs) are the most common uses of bioinformatics. In the past years, the scope of bioinformatics has extended significantly. Bioinformatics also tries to understand the structural principles within the nucleic acid and protein sequences, which are stated as proteomics.
Bio-Content Processing and Management Sector Accounted for the Largest Share in the Market
The major product variants of the bioinformatics market include bio-content processing and management, and genetic sequence platform. The bio-content processing and management sector accounted for the largest share in the market and is anticipated to expand at the fastest CAGR in the forthcoming period. The factors such as high usage rates of bioinformatics software and tools in database management is the primary reason attributing towards its large share in the bioinformatics in the years to come.
On the other hand, the genetic sequence platform are anticipated to witness a high revenue share in the years to come. The factors attributed to the growth of genetic sequence platform segment include increasing demand for exome and genome sequencing technologies as a result of decreasing prices of genetic sequencing. In addition, there have been numerous developments in genomic technology that have given rise to substantial improvements in availability of predication tools for secondary and tertiary structures of proteins and other biomolecules.
Expected development of imagining softwares used for high performance sequence examination comprising protein annotation, and DNA sequences, is also a factor anticipated to boost the bioinformatics growth over the forthcoming period.
Market Insights:
The key companies are involved in RNA sequencing capabilities to further decrease the prices of genome sequencing. The development of next generation sequencing technologies is anticipated to propel the bioinformatics industry in the forecast period. For example, in January 2018, Thermo Fisher Scientific announced Ion Gene Studio S5 Series, a line of extremely adaptable next generation sequencers.
Leading players operating in the bioinformatics market include BIOVIA; IBM Life Sciences; Life Technologies Corporation; 3rd Millennium Inc.; Agilent technologies; Celera Corporation; Bio Wisdom Ltd.; Rosetta Bio software; and Affymetrix.
No comments:
Post a Comment